Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Capucine Baldini

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Bulletin Du Cancer|April 10, 2021
[Why and how to assess older people with cancer?]Carole Helissey, Romain Geiss, Capucine Baldini, et al.
General Hospital Psychiatry|January 14, 2024
Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?Paul Matte, Matthieu Delaye, Alice Mc Govern, et al.
Current Oncology Reports|July 30, 2020
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review PaperNicolò Matteo Luca Battisti, Gabor Liposits, Nienke Aafke De Glas, et al.
Ultrasound in Medicine & Biology|May 19, 2015
VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic TreatmentsThomas Payen, Alexandre Dizeux, Capucine Baldini, et al.
Cancer Treatment Reviews|May 28, 2017
Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendationsAnna Rachelle Mislang, Tanya M Wildes, Ravindran Kanesvaran, et al.
Journal of Geriatric Oncology|January 19, 2023
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohortMichael Bringuier, Matthieu Carton, Didier Debieuvre, et al.
Investigational New Drugs|September 11, 2020
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancerAnalía Azaro, Capucine Baldini, Jordi Rodon, et al.
Journal of Geriatric Oncology|July 21, 2018
Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paperEsther Bastiaannet, Nicolò Battisti, Kah Poh Loh, et al.
Journal of Neuro-Oncology|April 1, 2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 studyCapucine Baldini, Philippe A Cassier, Jean-Pierre Delord, et al.
Bulletin Du Cancer|December 5, 2014
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors]Capucine Baldini, Boris Duchemann, Antoine Hollebecque, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Bulletin Du Cancer|April 10, 2021
[Why and how to assess older people with cancer?]Carole Helissey, Romain Geiss, Capucine Baldini, et al.
General Hospital Psychiatry|January 14, 2024
Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?Paul Matte, Matthieu Delaye, Alice Mc Govern, et al.
Current Oncology Reports|July 30, 2020
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review PaperNicolò Matteo Luca Battisti, Gabor Liposits, Nienke Aafke De Glas, et al.
Ultrasound in Medicine & Biology|May 19, 2015
VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic TreatmentsThomas Payen, Alexandre Dizeux, Capucine Baldini, et al.
Cancer Treatment Reviews|May 28, 2017
Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendationsAnna Rachelle Mislang, Tanya M Wildes, Ravindran Kanesvaran, et al.
Journal of Geriatric Oncology|January 19, 2023
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohortMichael Bringuier, Matthieu Carton, Didier Debieuvre, et al.
Investigational New Drugs|September 11, 2020
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancerAnalía Azaro, Capucine Baldini, Jordi Rodon, et al.
Journal of Geriatric Oncology|July 21, 2018
Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paperEsther Bastiaannet, Nicolò Battisti, Kah Poh Loh, et al.
Journal of Neuro-Oncology|April 1, 2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 studyCapucine Baldini, Philippe A Cassier, Jean-Pierre Delord, et al.
Bulletin Du Cancer|December 5, 2014
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors]Capucine Baldini, Boris Duchemann, Antoine Hollebecque, et al.
Pageof 11